New insights regarding HCV-NS5A structure/function and indication of genotypic differences

Detalhes bibliográficos
Autor(a) principal: Yamasaki, Lilian H. T. [UNESP]
Data de Publicação: 2012
Outros Autores: Arcuri, Helen A., Jardim, Ana Carolina G. [UNESP], Bittar, Cintia [UNESP], de Carvalho-Mello, Isabel Maria V. G., Rahal, Paula [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/1743-422X-9-14
http://hdl.handle.net/11449/21652
Resumo: Background: HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of similar to 50%. The mechanisms underlying viral resistance have not been elucidated but it has been suggested that both host and virus contribute to therapy outcome. Non-structural 5A (NS5A) protein, a critical virus component, is involved in cellular and viral processes.Methods: The present study analyzed structural and functional features of 345 sequences of HCV-NS5A genotypes 1 or 3, using in silico tools.Results: There was residue type composition and secondary structure differences between the genotypes. In addition, second structural variance were statistical different for each response group in genotype 3. A motif search indicated conserved glycosylation, phosphorylation and myristoylation sites that could be important in structural stabilization and function. Furthermore, a highly conserved integrin ligation site was identified, and could be linked to nuclear forms of NS5A. ProtFun indicated NS5A to have diverse enzymatic and nonenzymatic activities, participating in a great range of cell functions, with statistical difference between genotypes.Conclusion: This study presents new insights into the HCV-NS5A. It is the first study that using bioinformatics tools, suggests differences between genotypes and response to therapy that can be related to NS5A protein features. Therefore, it emphasizes the importance of using bioinformatics tools in viral studies. Data acquired herein will aid in clarifying the structure/function of this protein and in the development of antiviral agents.
id UNSP_848b039eba6baaf708c1dc26683f2709
oai_identifier_str oai:repositorio.unesp.br:11449/21652
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling New insights regarding HCV-NS5A structure/function and indication of genotypic differencesHepatitis C virusNon-structural 5A proteinBioinformaticsGenotypeQuasispeciesIFN responseBackground: HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of similar to 50%. The mechanisms underlying viral resistance have not been elucidated but it has been suggested that both host and virus contribute to therapy outcome. Non-structural 5A (NS5A) protein, a critical virus component, is involved in cellular and viral processes.Methods: The present study analyzed structural and functional features of 345 sequences of HCV-NS5A genotypes 1 or 3, using in silico tools.Results: There was residue type composition and secondary structure differences between the genotypes. In addition, second structural variance were statistical different for each response group in genotype 3. A motif search indicated conserved glycosylation, phosphorylation and myristoylation sites that could be important in structural stabilization and function. Furthermore, a highly conserved integrin ligation site was identified, and could be linked to nuclear forms of NS5A. ProtFun indicated NS5A to have diverse enzymatic and nonenzymatic activities, participating in a great range of cell functions, with statistical difference between genotypes.Conclusion: This study presents new insights into the HCV-NS5A. It is the first study that using bioinformatics tools, suggests differences between genotypes and response to therapy that can be related to NS5A protein features. Therefore, it emphasizes the importance of using bioinformatics tools in viral studies. Data acquired herein will aid in clarifying the structure/function of this protein and in the development of antiviral agents.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)São Paulo State Univ UNESP, Dept Biol, Sao Jose do Rio Preto, SP, BrazilSão Paulo Univ USP, Dept Clin Med, São Paulo, BrazilInstituto Butantan, Viral Immunol Lab, São Paulo, BrazilLab Estudos Genom, BR-15054000 Sao Jose do Rio Preto, SP, BrazilSão Paulo State Univ UNESP, Dept Biol, Sao Jose do Rio Preto, SP, BrazilBiomed Central Ltd.Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Instituto ButantanLab Estudos GenomYamasaki, Lilian H. T. [UNESP]Arcuri, Helen A.Jardim, Ana Carolina G. [UNESP]Bittar, Cintia [UNESP]de Carvalho-Mello, Isabel Maria V. G.Rahal, Paula [UNESP]2014-05-20T14:01:17Z2014-05-20T14:01:17Z2012-01-12info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10application/pdfhttp://dx.doi.org/10.1186/1743-422X-9-14Virology Journal. London: Biomed Central Ltd., v. 9, p. 10, 2012.1743-422Xhttp://hdl.handle.net/11449/2165210.1186/1743-422X-9-14WOS:000304652900001WOS000304652900001.pdf79910823626712120000-0001-5693-6148Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengVirology Journal2.465info:eu-repo/semantics/openAccess2023-11-23T06:11:22Zoai:repositorio.unesp.br:11449/21652Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:29:31.045761Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv New insights regarding HCV-NS5A structure/function and indication of genotypic differences
title New insights regarding HCV-NS5A structure/function and indication of genotypic differences
spellingShingle New insights regarding HCV-NS5A structure/function and indication of genotypic differences
Yamasaki, Lilian H. T. [UNESP]
Hepatitis C virus
Non-structural 5A protein
Bioinformatics
Genotype
Quasispecies
IFN response
title_short New insights regarding HCV-NS5A structure/function and indication of genotypic differences
title_full New insights regarding HCV-NS5A structure/function and indication of genotypic differences
title_fullStr New insights regarding HCV-NS5A structure/function and indication of genotypic differences
title_full_unstemmed New insights regarding HCV-NS5A structure/function and indication of genotypic differences
title_sort New insights regarding HCV-NS5A structure/function and indication of genotypic differences
author Yamasaki, Lilian H. T. [UNESP]
author_facet Yamasaki, Lilian H. T. [UNESP]
Arcuri, Helen A.
Jardim, Ana Carolina G. [UNESP]
Bittar, Cintia [UNESP]
de Carvalho-Mello, Isabel Maria V. G.
Rahal, Paula [UNESP]
author_role author
author2 Arcuri, Helen A.
Jardim, Ana Carolina G. [UNESP]
Bittar, Cintia [UNESP]
de Carvalho-Mello, Isabel Maria V. G.
Rahal, Paula [UNESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
Instituto Butantan
Lab Estudos Genom
dc.contributor.author.fl_str_mv Yamasaki, Lilian H. T. [UNESP]
Arcuri, Helen A.
Jardim, Ana Carolina G. [UNESP]
Bittar, Cintia [UNESP]
de Carvalho-Mello, Isabel Maria V. G.
Rahal, Paula [UNESP]
dc.subject.por.fl_str_mv Hepatitis C virus
Non-structural 5A protein
Bioinformatics
Genotype
Quasispecies
IFN response
topic Hepatitis C virus
Non-structural 5A protein
Bioinformatics
Genotype
Quasispecies
IFN response
description Background: HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of similar to 50%. The mechanisms underlying viral resistance have not been elucidated but it has been suggested that both host and virus contribute to therapy outcome. Non-structural 5A (NS5A) protein, a critical virus component, is involved in cellular and viral processes.Methods: The present study analyzed structural and functional features of 345 sequences of HCV-NS5A genotypes 1 or 3, using in silico tools.Results: There was residue type composition and secondary structure differences between the genotypes. In addition, second structural variance were statistical different for each response group in genotype 3. A motif search indicated conserved glycosylation, phosphorylation and myristoylation sites that could be important in structural stabilization and function. Furthermore, a highly conserved integrin ligation site was identified, and could be linked to nuclear forms of NS5A. ProtFun indicated NS5A to have diverse enzymatic and nonenzymatic activities, participating in a great range of cell functions, with statistical difference between genotypes.Conclusion: This study presents new insights into the HCV-NS5A. It is the first study that using bioinformatics tools, suggests differences between genotypes and response to therapy that can be related to NS5A protein features. Therefore, it emphasizes the importance of using bioinformatics tools in viral studies. Data acquired herein will aid in clarifying the structure/function of this protein and in the development of antiviral agents.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-12
2014-05-20T14:01:17Z
2014-05-20T14:01:17Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1743-422X-9-14
Virology Journal. London: Biomed Central Ltd., v. 9, p. 10, 2012.
1743-422X
http://hdl.handle.net/11449/21652
10.1186/1743-422X-9-14
WOS:000304652900001
WOS000304652900001.pdf
7991082362671212
0000-0001-5693-6148
url http://dx.doi.org/10.1186/1743-422X-9-14
http://hdl.handle.net/11449/21652
identifier_str_mv Virology Journal. London: Biomed Central Ltd., v. 9, p. 10, 2012.
1743-422X
10.1186/1743-422X-9-14
WOS:000304652900001
WOS000304652900001.pdf
7991082362671212
0000-0001-5693-6148
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Virology Journal
2.465
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd.
publisher.none.fl_str_mv Biomed Central Ltd.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128938340253696